======= IREB2 ======= == Gene Information == * **Official Symbol**: IREB2 * **Official Name**: iron responsive element binding protein 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3658|3658]] * **UniProt**: [[https://www.uniprot.org/uniprot/P48200|P48200]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IREB2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IREB2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/147582|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Aconitase| |Aconitase C| |iron-responsive element binding| |aconitate hydratase activity| |citrate metabolic process| |protoporphyrinogen IX biosynthetic process| |protoporphyrinogen IX metabolic process| |translation repressor activity| |tricarboxylic acid metabolic process| |heme biosynthetic process| |porphyrin-containing compound biosynthetic process| |tetrapyrrole biosynthetic process| |heme metabolic process| |intestinal absorption| |tricarboxylic acid cycle| |porphyrin-containing compound metabolic process| |4 iron, 4 sulfur cluster binding| |osteoclast differentiation| |pigment biosynthetic process| |tetrapyrrole metabolic process| |cellular iron ion homeostasis| |pigment metabolic process| |iron ion transport| |digestive system process| |aerobic respiration| |iron ion homeostasis| |erythrocyte homeostasis| |post-embryonic development| |antibiotic metabolic process| |cellular transition metal ion homeostasis| |myeloid cell homeostasis| |myeloid leukocyte differentiation| |digestion| |transition metal ion transport| |negative regulation of translation| |transition metal ion homeostasis| |negative regulation of cellular amide metabolic process| |cellular respiration| |homeostasis of number of cells| |cofactor biosynthetic process| |myeloid cell differentiation| |energy derivation by oxidation of organic compounds| |leukocyte differentiation| |regulation of translation| |regulation of cellular amide metabolic process| |generation of precursor metabolites and energy| |cofactor metabolic process| |drug metabolic process| |posttranscriptional regulation of gene expression| |hemopoiesis| |cellular metal ion homeostasis| |hematopoietic or lymphoid organ development| |metal ion homeostasis| |cellular cation homeostasis| |metal ion transport| |cellular ion homeostasis| |immune system development| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |ion homeostasis| |cation transport| |cellular homeostasis| |carboxylic acid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |chemical homeostasis| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |mitochondrion| |organic cyclic compound biosynthetic process| |ion transport| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |organonitrogen compound biosynthetic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |cellular nitrogen compound biosynthetic process| |homeostatic process| |negative regulation of gene expression| |small molecule metabolic process| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp346|CoCl2 18μM R07 exp346]]|-2.62| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-2.6| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-2.45| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.38| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-2.29| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-2.03| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-2.01| |[[:results:exp539|42°C R08 exp539]]|-1.83| |[[:results:exp347|Cyclosporin-A 0.8μM R07 exp347]]|-1.77| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|1.77| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|2.12| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.38| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|2.76| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|2.93| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.517| |[[:human genes:a:ankh|ANKH]]|0.429| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16626 * **Expression level (log2 read counts)**: 7.54 {{:chemogenomics:nalm6 dist.png?nolink |}}